Purchases and Sales Made in Q1 2023 in Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL) during Q1 2023. The information is specifically focused on institutions that hold shares of Achilles Therapeutics plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
284KNew |
$238K - $357K
|
284K
$329K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
45.5K+ 55.65% |
$38.2K - $57.3K
|
127K
$148K
|
|
|
May 11, 2023
Q1 2023
|
Forefront Analytics, LLC
West Conshohocken, PA |
BUY
|
- |
45.1K+ 147.75% |
$37.9K - $56.8K
|
75.6K
$87.7K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
42.3K+ 169.05% |
$35.5K - $53.2K
|
67.2K
$78K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
12.4KNew |
$10.4K - $15.6K
|
12.4K
$14.4K
|
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
4.63K+ 43.35% |
$3.89K - $5.83K
|
15.3K
$17.7K
|
|
|
May 02, 2023
Q1 2023
|
Endurance Wealth Management, Inc.
|
BUY
|
- |
2K+ 99900.0% |
$1.68K - $2.52K
|
2K
$2.32K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2023
Q1 2023
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-2.41K- 0.85% |
$2.02K - $3.03K
|
282K
$327K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-105K- 21.56% |
$87.8K - $132K
|
380K
$441K
|